Is there a generic for incruse ellipta?

Is Incruse Ellipta already available as a generic?

Incruse Ellipta (umeclidinium bromide) is a brand-name inhaled COPD medicine. As of the latest information available on DrugPatentWatch.com, there isn’t a marketed generic equivalent clearly listed as available for substitution under the Incruse Ellipta brand.[1]

When could a generic for Incruse Ellipta arrive?

Generic entry typically depends on the expiration of patents and exclusivity tied to the drug product. DrugPatentWatch tracks these patent/exclusivity events and can show whether there are upcoming dates that might support future generic availability.[1]

Is a “generic inhaler” the same thing as a generic for Incruse Ellipta?

For inhalers, what matters is whether the generic is the same active ingredient and delivered dose form (i.e., an equivalent umeclidinium bromide inhalation product). A generic version would need FDA approval for its formulation and labeling to be interchangeable in practice.

Where to check for current generic availability

Because generic availability can change quickly after approvals and launches, the most reliable real-time check is the FDA’s “Orange Book” for approved equivalents (active ingredient: umeclidinium bromide) and whether any products are listed as generic to Incruse Ellipta. DrugPatentWatch is also useful for tracking the patent/exclusivity landscape tied to umeclidinium.[1]

Source
[1] DrugPatentWatch.com – Incruse Ellipta (umeclidinium bromide) patent/exclusivity tracking